उत्पाद वर्णन
About V-Immune Injection
V-Immune Injection belongs to the class of medications called 'immunising agents used to treat immunoglobulin (antibody) deficiency and certain inflammatory disorders. It is used to treat immunoglobulin deficiency in people with primary immunodeficiency or PID (present from birth) and secondary immunodeficiency or SID (developed in the later stages of life). V-Immune Injection is also used to treat inflammatory disorders such as primary immune thrombocytopenia (reduced number of platelets), Guillain-Barre syndrome (short-term inflammation of the peripheral nerves causing weakness of legs and upper limbs), Kawasaki disease (inflammation of blood vessels in children), chronic inflammatory demyelinating polyneuropathy or CIDP (long-term inflammation of peripheral nerves), and multifocal motor neuropathy (progressive disease leading to weakness of arms and legs).
Enhanced Immune ProtectionV-Immune 5 g Injection assists individuals with compromised immunity by providing essential antibodies, thereby reducing their risk of serious infections. As a replacement therapy, it bridges the gap in antibody deficiency, ensuring the patient's immune system remains fortified against pathogens. Regular administration, as directed by a physician, can significantly contribute to improved wellbeing and infection prevention.
Safe and Targeted AdministrationAdministered exclusively via intravenous infusion, V-Immune is to be given in a controlled medical setting by healthcare professionals. The process is closely monitored to detect and manage potential infusion reactions, ensuring patient safety and efficacy of the treatment. Patients should remain under observation during and after the infusion for optimal care.
Stringent Quality and Storage StandardsV-Immune 5 g Injection is manufactured adhering to rigorous pharmaceutical quality measures and is packaged as a single vial per box. To retain its efficacy, it must be stored at a temperature range of 2C to 8C and never frozen, ensuring stability and effectiveness throughout its 24-month shelf life. Proper storage and handling are crucial for maintaining its therapeutic value.
FAQ's of V immune 5 g Injection:
Q: How is V-Immune 5 g Injection administered and who should perform the infusion?
A: V-Immune 5 g Injection is administered intravenously by a healthcare professional. The infusion should take place in a clinical setting under medical supervision to monitor for any infusion reactions and ensure patient safety.
Q: What conditions is V-Immune recommended for and how does it benefit patients?
A: This injection is recommended for adults with immunodeficiency disorders needing replacement therapy. It provides passive immunity by supplying essential antibodies, thereby preventing infections and supporting immune health in vulnerable individuals.
Q: When should V-Immune not be used?
A: V-Immune must not be used in patients with known hypersensitivity to immunoglobulins or those with IgA deficiency. Always consult your physician to discuss potential risks and contraindications before starting therapy.
Q: Where should V-Immune 5 g Injection be stored to maintain its effectiveness?
A: Store V-Immune at 2C to 8C in a refrigerator. Avoid freezing the solution, and keep it in its original packaging until use to protect from light and contamination.
Q: What precautions should be taken during and after receiving V-Immune?
A: Patients should be monitored for possible infusion reactions during and after administration. Use only under medical supervision, and inform your healthcare provider about any previous allergies or reactions to immunoglobulin therapies.
Q: What is the process for using V-Immune 5 g Injection?
A: The product is administered as a slow intravenous infusion by medical staff. Dosage and infusion rate are determined by the physician based on individual requirements and medical history. Patients will be observed throughout the procedure for safety.